Incentivize innovation, protect investments, attract funding, enable collaboration, and foster advancements in the healthcare and science industry through the comprehensive software and services available through IP.com®. Provide tangible value by granting exclusive rights, facilitating commercialization, and establishing a competitive edge for your company.
HealtHcare Innovation
Innovation is vital for the healthcare and science industries because it leads to better outcomes, increased efficiency, cost savings, and advances in knowledge. It plays a crucial role in addressing current and future health challenges and contributes to the overall well-being of individuals and society as a whole.
Innovation is the lifeblood of the healthcare and science industries. It drives progress, improves patient outcomes, increases efficiency, and enhances our understanding of the natural world. These innovations ultimately benefit individuals, healthcare providers, researchers, and society as a whole. The development of new drugs, surgical techniques, and medical devices can save lives and enhance the quality of life for patients. Innovation can lead to more efficient healthcare delivery and cost-effective solutions. Streamlining processes, implementing telemedicine, and using data analytics can help reduce healthcare costs and make healthcare services more accessible to a broader population.
The faster the innovation process, the quicker these impacts will be felt by society as a whole. IP.com is dedicated to providing software and solutions that accelerate the ideation process and encourage the efficiency of the patenting and defensive publishing of new IP.
Advancing Medical Knowledge
The IP Suite is built around the goal of maximizing the efficiency of the innovative process. Innovation in scientific research contributes to the expansion of medical knowledge. This includes discoveries related to disease mechanisms, treatment options, drug development, and understanding the human body’s intricacies. Advances in genomics and data analytics enable the customization of treatment plans based on an individual’s genetic makeup and health characteristics, maximizing treatment effectiveness and minimizing side effects.
Improving Care
Services provided by the team at IP.com deliver a highly detailed analysis of competitor innovations and patents so R&D teams can strategically prioritize new research and advancements. Innovative medical treatments, therapies, and technologies enhance patient care. For instance, the development of minimally invasive surgical techniques reduces recovery times and complications, while new drugs target specific diseases with greater precision, leading to better outcomes. Innovations in diagnostic tools and technologies enable earlier and more accurate disease detection. This can lead to timely interventions and improved prognosis.
Medical Discovery
IP.com’s services and solutions accelerate R&D innovation workflows to get to market faster. Innovation is central to drug discovery, from high-throughput screening to computational modeling. Advanced technologies like CRISPR gene editing have opened up new possibilities for drug development. The rapid development of vaccines for emerging diseases, such as COVID-19, highlights the crucial role of innovation in public health. Innovative approaches to vaccine development, such as mRNA technology, have the potential to revolutionize vaccine creation.
Tailored Solutions
IQ Ideas+™
IQ Ideas+™ is unique in the market, filling a gap that traditional problem-solving tools and methodologies fail to address. It helps innovators and engineers generate and refine ideas with the most significant potential at the source of the process—before precious time and resources are wasted—so you can accelerate ROI.
Technology Vitality Report
Our Technology Vitality Report uses a proprietary AI engine to power comprehensive IP evaluation, allowing you to rank ideas quickly, efficiently, and transparently. Get quick and thorough decisions with our Technology Vitality Report (TVR) and improve your review process with less effort.
Defensive Publishing
Defensive publishing is the intentional and purposeful publication of innovation into the public domain. It is a cost-effective IP strategy that discloses aspects of your invention so it becomes prior art.
Patent Vitality Report
The Patent Vitality Report (PVR) gives patent owners, buyers, and sellers an objective analysis of the assets in a patent portfolio. It provides valuable patent analysis in five understandable scores: overall strength, litigation risk, monetization potential, new technology value, and patent quality.
Patents in Academia News
The Importance of the National Artificial Intelligence Research Resource (NAIRR) Pilot to Public Research
The collaborative nature of the NIARR pilot, bringing together academia, industry, nonprofit and government sectors, is intended to promote cross-sector partnerships. Industry collaboration can lead to the development of commercially viable AI applications and solutions, fostering economic growth by creating new markets and revenue streams.
Join IP.com at Booth #111 for Exclusive AI Innovations at FLC National Meeting 2024
IP.com is sponsoring the FLC National Meeting 2024. Join us on April 9-11 for key insights on federal tech transfer. Don’t miss our presentation on Generative AI for Structured Ideation and preview our AI-powered IP solutions!
The Palworld Phenomenon and Copyright Infringement in the Viral, Fast-Paced Gaming Industry
During Palworld’s massive launch, more and more players and spectators online began to throw some hefty accusations at Pocketpair. While the Pokémon comparison is clear, some have called into question both how Pals were created, claiming the use of A.I., and how similar some are to Game Freak’s own Pokémon designs. Neither Nintendo, Game Freak, nor The Pokémon Company have commented on Palworld and its Pal design similarities to Pokémon.